search
Back to results

The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity

Primary Purpose

Diabetes, Hypoglycemia Unawareness

Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Hypoglycemia
Sponsored by
Radboud University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Diabetes focused on measuring Hypoglycemia unawareness, Diabetes, adrenal receptor, adrenerg respons, adrenergic beta-agonists, salbutamol

Eligibility Criteria

18 Years - 40 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Informed consent Homozygous for Arginine at codon 16 or homozygous Gly at codon 16 No regular usage of medication other than oral contraceptives Exclusion Criteria: History of cerebrovascular, cardiovascular, or peripheral vascular disease Smoking Alcohol usage of more than 10 units per week Inability to abstain from xanthine-derivatives (coffee, tea, cola, chocolate, cacao) or alcohol for 2 days BMI above 30 kg/m2 Participation to any other trial in the preceding 3 months Ongoing disease of any kind Pregnancy

Sites / Locations

  • Radboud University Nijmegen Medical Centre

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Hypoglycemia

Arm Description

Intrerfvention is a hypoglycemic stimulus

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
September 9, 2005
Last Updated
May 8, 2015
Sponsor
Radboud University Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00160056
Brief Title
The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity
Official Title
The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity in Subjects With Homozygous Arg16 and gly16 Polymorphism of the β2-adrenergic Receptor
Study Type
Interventional

2. Study Status

Record Verification Date
May 2015
Overall Recruitment Status
Completed
Study Start Date
April 2005 (undefined)
Primary Completion Date
April 2009 (Actual)
Study Completion Date
April 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Radboud University Medical Center

4. Oversight

5. Study Description

Brief Summary
Hypoglycaemia unawareness is a common complication in patients with type 1 diabetes and with insulin-treated type 2 diabetes of long duration. The loss of autonomic symptoms to hypoglycemia does not solely depend on loss of adrenaline responses.Differences in sensitivity to catecholamines may also be involved. Reconciling the data on β2-adrenergic receptor polymorphism to those on loss of β-adrenergic sensitivity in diabetic patients with hypoglycemia unawareness, we hypothesize that hypoglycemia unawareness is at least partly the result of desensitization of the β2-adrenergic receptor and that patients who are homozygous for arginine at codon 16 are particularly susceptible for this desensitization process, whereas patients who are homozygous for glycine at codon 16 are resistant for desensitization. Objectives To determine whether, and if so to what extent, antecedent hypoglycemia reduces β2-adrenergic sensitivity in healthy subjects with Arg16 homozygosity. To investigate whether or not healthy subjects with Gly16 homozygosity are resistant to desensitization To confirm that antecedent hypoglycemia reduces the heart rate response to isoproterenol and to assess to what extent this reduced response is mediated by impairments in baroreflex sensitivity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes, Hypoglycemia Unawareness
Keywords
Hypoglycemia unawareness, Diabetes, adrenal receptor, adrenerg respons, adrenergic beta-agonists, salbutamol

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
16 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Hypoglycemia
Arm Type
Other
Arm Description
Intrerfvention is a hypoglycemic stimulus
Intervention Type
Procedure
Intervention Name(s)
Hypoglycemia

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Informed consent Homozygous for Arginine at codon 16 or homozygous Gly at codon 16 No regular usage of medication other than oral contraceptives Exclusion Criteria: History of cerebrovascular, cardiovascular, or peripheral vascular disease Smoking Alcohol usage of more than 10 units per week Inability to abstain from xanthine-derivatives (coffee, tea, cola, chocolate, cacao) or alcohol for 2 days BMI above 30 kg/m2 Participation to any other trial in the preceding 3 months Ongoing disease of any kind Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul Smits, PhD, MD
Organizational Affiliation
Radboud University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Radboud University Nijmegen Medical Centre
City
Nijmegen
State/Province
Gelderland
ZIP/Postal Code
6500HB
Country
Netherlands

12. IPD Sharing Statement

Citations:
PubMed Identifier
21298412
Citation
Schouwenberg BJ, Smits P, Tack CJ, de Galan BE. The effect of antecedent hypoglycaemia on beta(2)-adrenergic sensitivity in healthy participants with the Arg16Gly polymorphism of the beta(2)-adrenergic receptor. Diabetologia. 2011 May;54(5):1212-8. doi: 10.1007/s00125-011-2062-3. Epub 2011 Feb 6.
Results Reference
derived

Learn more about this trial

The Effect of Antecedent Hypoglycaemia on β2-adrenergic Sensitivity

We'll reach out to this number within 24 hrs